MBRX - Moleculin Biote Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (%) TVIX (%) VXX (3.65%) SPLK (%) TQQQ (%) SPX (-0.51%) ZS (1.57%) SPOT (-2.13%) TLRY (%) TGEN (%) SYNH (%) SUPV (%) QQQ (%) PNC (-0.06%) PINS (-1.07%) PFE (0.39%) PANW (0.59%) MELI (%) MCD (-0.5%) IWM (%) GSK (%) GLD (%) EW (%) CMI (%) CLUB (0.75%)

MBRX - Moleculin Biotech

$1.16 -0.01[%]

15 mins delayed data

People also watch : OPHLY | ONCX | OMER

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Moleculin Announces CTRC Approval of WP1...	08/20/19
HOUSTON, Aug. 20, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a ...

Moleculin Biotech, Inc. Reports Financia...	08/16/19
HOUSTON, Aug. 16, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a ...

Moleculin Completes Enrollment in Early-...	08/15/19
Moleculin (MBRX) reaches enrollment target in a clinical study evaluating its p-STAT3 inhibitor, WP1220, as a treatment for cutaneous T-cell lymphoma,...

Moleculin Announces Completion of Lympho...	08/13/19
HOUSTON, Aug. 13, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a ...

Moleculin Announces Breakthrough Discove...	08/06/19
HOUSTON, Aug. 6, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a b...

HOLDERS

% Insider	12.52%	% Institutional	76.43%

Top 10 Institutional Owners

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%

Previous Close	$1.17	Open	$1.17
Volume	5.6K	Market Cap	54.68M
Yield		Last Dividend

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

Service Name	Trader	% Success
Big Data Kornacki & Zhou	Zhou Academy	90.00 %	Subscribe
Mojo Day Trading	ProTrader Mike	47.00 %	Subscribe

MBRX - Moleculin Biotech

$1.16 -0.01[%]

Add to New List:

Day

52 Week

ANALYST RATINGS

0.00 %

Price Target (PT)

EARNINGS

FINANCE

HOLDERS

Top 10 Institutional Owners

TRADERS TRACKING $MBRX

About Us

Product Types

Strategies

Follow Us

Secure Payments